The current price of GRI is $1.55 — it has increased by 8.39% since the previous close. Data as of Nov 5, 2026.
GRI is down 2.52% over the past week, down 18.85% over the past month and down 96.70% over the past year. The price is below its 200-day moving average of $2.16.
Of the 2 analysts covering GRI Bio, Inc., 2 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
GRI Bio, Inc. has a market capitalization of $3.39M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, GRI Bio, Inc. posted a loss of $0.91 per share against an estimate of -$1.19, beating expectations by 23.53%. Upcoming reports are listed in the earnings calendar.
GRI Bio, Inc. has not paid any dividends over the past year.
In the latest trading session GRI moved between $1.48 and $1.64, a range of 10.32% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of GRI Bio, Inc. shows a neutral rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for GRI Bio, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GRI has traded between $1.36 and $64.12. The current price is 97.58% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.